|
|
Blood, 15 July 2005, Vol. 106, No. 2, pp. 641-649.
Prepublished online as a Blood First Edition Paper on April 5, 2005; DOI 10.1182/blood-2004-12-4589.
Previous Article | Next Article 
Submitted December 2, 2004
Accepted March 29, 2005
Indole-3-carbinol suppresses NF- B and I B kinase activation causing inhibition of expression of NF- B-regulated antiapoptotic and metastatic gene products and enhancement of apoptosis in myeloid and leukemia cells
Yasunari Takada, Michael Andreeff, and Bharat B Aggarwal*
Cytokine Research Laboratory, Department of Experimental Therapeutics, The University of Texas M. D. Anderson Cancer Center, Houston, TX, USA
Section of Molecular Hematology and Therapy, Department of Blood and Marrow Transplantation, The University of Texas M. D. Anderson Cancer Center, Houston, TX, USA
* Corresponding author; email: aggarwal{at}mdanderson.org.
Indole-3-carbinol, found in Brassica sp. vegetables (such as cabbage, cauliflower, and brussels spouts), exhibits antitumor effects through poorly defined mechanisms. Because several genes that regulate apoptosis, proliferation, and metastasis are regulated by NF- B, we postulated that indole-3-carbinol must mediate its activity through NF- B modulation. We demonstrated that indole-3-carbinol suppressed constitutive NF- B activation and activation induced by TNF, IL-1 , PMA, LPS, and cigarette smoke; the suppression was not cell type specific, as activation was inhibited in myeloid, leukemia, and epithelial cells. This activation correlated with the sequential suppression of the I B kinase, I B phosphorylation, I B ubiquitination, I B degradation, p65 phosphorylation, p65 nuclear translocation, and p65 acetylation and with NF- B-dependent reporter gene expression. The NF- B-regulated gene products cyclin D1, COX-2, MMP-9, survivin, IAP1, IAP2, XIAP, Bcl-2, Bfl-1/A1, TRAF1, and FLIP were all downregulated by indole-3-carbinol. This downregulation led to the potentiation of apoptosis induced by cytokines and chemotherapeutic agents. Indole-3-carbinol suppressed constitutive NF- B activation in mononuclear cells derived from bone marrow of acute myelogenous leukemia patients and this correlated with inhibition of cell growth. Overall, our results indicated that indole-3-carbinol inhibits NF- B and NF- B-regulated gene expression and that this mechanism may provide the molecular basis for its ability to suppress tumorigenesis.

CiteULike Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
F. S. Khwaja, S. Wynne, I. Posey, and D. Djakiew
3,3'-Diindolylmethane Induction of p75NTR-Dependent Cell Death via the p38 Mitogen-Activated Protein Kinase Pathway in Prostate Cancer Cells
Cancer Prevention Research,
June 1, 2009;
2(6):
566 - 571.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. O. Ban, J. H. Oh, B. Y. Hwang, D. C. Moon, H.-S. Jeong, S. Lee, S. Kim, H. Lee, K.-B. Kim, S. B. Han, et al.
Inflexinol inhibits colon cancer cell growth through inhibition of nuclear factor-{kappa}B activity via direct interaction with p50
Mol. Cancer Ther.,
June 1, 2009;
8(6):
1613 - 1624.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Hu, Y. Shikama, I. Matsuoka, and J. Kimura
Terminally differentiated neutrophils predominantly express Survivin-2{alpha}, a dominant-negative isoform of Survivin
J. Leukoc. Biol.,
February 1, 2008;
83(2):
393 - 400.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Sors, F. Jean-Louis, E. Begue, L. Parmentier, L. Dubertret, M. Dreano, G. Courtois, H. Bachelez, and L. Michel
Inhibition of I{kappa}B Kinase Subunit 2 in Cutaneous T-Cell Lymphoma Down-Regulates Nuclear Factor-{kappa}B Constitutive Activation, Induces Cell Death, and Potentiates the Apoptotic Response to Antineoplastic Chemotherapeutic Agents
Clin. Cancer Res.,
February 1, 2008;
14(3):
901 - 911.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F.-M. Lin, L.-R. Chen, E.-H. Lin, F.-C. Ke, H.-Y. Chen, M.-J. Tsai, and P.-W. Hsiao
Compounds from Wedelia chinensis synergistically suppress androgen activity and growth in prostate cancer cells
Carcinogenesis,
December 1, 2007;
28(12):
2521 - 2529.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Kaileh, W. Vanden Berghe, A. Heyerick, J. Horion, J. Piette, C. Libert, D. De Keukeleire, T. Essawi, and G. Haegeman
Withaferin A Strongly Elicits I{kappa}B Kinase beta Hyperphosphorylation Concomitant with Potent Inhibition of Its Kinase Activity
J. Biol. Chem.,
February 16, 2007;
282(7):
4253 - 4264.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Khan, F. Afaq, and H. Mukhtar
Apoptosis by dietary factors: the suicide solution for delaying cancer growth
Carcinogenesis,
February 1, 2007;
28(2):
233 - 239.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S.-H. Chiou, Y.-P. Yang, J.-C. Lin, C.-H. Hsu, H.-C. Jhang, Y.-T. Yang, C.-H. Lee, L. L. T. Ho, W.-M. Hsu, H.-H. Ku, et al.
The Immediate Early 2 Protein of Human Cytomegalovirus (HCMV) Mediates the Apoptotic Control in HCMV Retinitis through Up-Regulation of the Cellular FLICE-Inhibitory Protein Expression
J. Immunol.,
November 1, 2006;
177(9):
6199 - 6206.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. W. Rahman, F. H. Sarkar, S. Banerjee, Z. Wang, D. J. Liao, X. Hong, and N. H. Sarkar
Therapeutic intervention of experimental breast cancer bone metastasis by indole-3-carbinol in SCID-human mouse model.
Mol. Cancer Ther.,
November 1, 2006;
5(11):
2747 - 2756.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. J. Auborn
Can Indole-3-Carbinol-Induced Changes in Cervical Intraepithelial Neoplasia Be Extrapolated to Other Food Components?
J. Nutr.,
October 1, 2006;
136(10):
2676S - 2678S.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. F. McCarty and K. I. Block
Preadministration of High-Dose Salicylates, Suppressors of NF-{kappa}B Activation, May Increase the Chemosensitivity of Many Cancers: An Example of Proapoptotic Signal Modulation Therapy
Integr Cancer Ther,
September 1, 2006;
5(3):
252 - 268.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Braun, G. Carvalho, A. Coquelle, M.-C. Vozenin, P. Lepelley, F. Hirsch, J.-J. Kiladjian, V. Ribrag, P. Fenaux, and G. Kroemer
NF-{kappa}B constitutes a potential therapeutic target in high-risk myelodysplastic syndrome
Blood,
February 1, 2006;
107(3):
1156 - 1165.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|
|